Sorry ditch, Rightly so, they did not disclose specifics, But...

Sorry ditch,

Rightly so, they did not disclose specifics,
But rather general information.

For what it's worth, the key take aways they gave.

1.No change in guidance.

2.continue to advance existing products
towards deals

3. An increase in co developments and opportunities

4. Very excited about the potential of Anagrelide.

This was to try to help long-term holders.

I am in for the long term!!

As i said before, contact the company!!

Btw, if you don't like what i say, please put me on 'ignore'